Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
RSV, flu, COVID-19, norovirus on rise. See symptoms, facts
What virus is going around? RSV, flu and COVID-1 cases rise in Tennessee and nationwide. What to know
State and federal data show high levels of respiratory illnesses. Here's what to know about the illnesses circulating this winter, their symptoms and how to prevent them.
RSV, flu, COVID-19, norovirus on the rise. See symptoms, facts
Several viruses are causing illnesses in Ohio and the U.S. See the symptoms for COVID-19, RSV, flu, norovirus and bird flu.
Where are COVID, flu and RSV cases rising in the US? See maps
Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and Prevention. But there's a fourth "bug" the public should be aware of: respiratory syncytial virus. RSV causes cold-like symptoms and affects the breathing passages and lungs.
Flu, RSV, Norovirus, other viruses are on the rise
“The last several weeks we’ve started to see a definite increase in influenza-like illnesses, which cover influenza, RSV, COVID-19 can also fall under that type of picture. We’ve also been seeing an increase of norovirus and norovirus-like illnesses,” says Simmons.
With flu and RSV on the rise, how Colorado Springs is trying to keep healthy
State Public Health Data shows flu and RSV hospitalizations are rising. Officials say this season is similar to pre-COVID years.
FDA, GSK and RSV
FDA Adds Guillain-Barre Syndrome Warning to Two RSV Vaccines
Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC continued to monitor for GBS risk. FDA conducted a postmarket
RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare neurological condition that can cause paralysis.
GSK, Pfizer RSV shots must warn about rare paralysis risk
Barré for every million doses given.
19m
Research shows 8 in 10 infants received RSV protection in the 2023 to 2024 season
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...
WHTM Harrisburg on MSN
4h
What’s Going Around: Flu, RSV, stomach bug
UPMC Children’s Community Pediatrics IS seeing an increase in cases of flu and RSV this week. WellSpan Pediatric Medicine ...
ABC Action News
1h
Doctors tracking a big increase in flu and RSV cases
Doctors are tracking a large increase in flu and RSV cases, and they're calling this a busy respiratory season.
1d
RSV emergency department visits remain high in Florida. What to know
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
Medscape
2d
RSV Vaccines and Treatments Face Global Access Hurdles
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
2d
Georgia has high levels of RSV in wastewater, CDC says: What to do if you contract RSV
Georgia was one of 18 states with "high" or "very high" levels in wastewater, according to CDC monitoring. Here's what to ...
1h
Flu and RSV cases climb over recent weeks in Florida
Doctors and other health professionals said influenza and RSV are both spreading around Florida and could get worse over the ...
3h
Seven signs you need to call an ambulance for child with RSV as GP says symptoms can ‘easily be mistaken for cold’
A GP has told how RSV symptoms can be “easily mistaken” for a cold – and revealed when it’s time to call an ambulance for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
China
Covid
flu
Pfizer
GSK
Feedback